section 27 implant devices and materials
play

Section 27: Implant Devices and Materials 27-1 From: Ploeg 27-2 - PDF document

Section 27: Implant Devices and Materials 27-1 From: Ploeg 27-2 From: Ploeg 27-3 From: Ploeg 27-4 What are the goals of TJR? What are the goals of TJR? Improve quality of life Improve quality of life Reduce pain Restore


  1. Section 27: Implant Devices and Materials 27-1

  2. From: Ploeg 27-2

  3. From: Ploeg 27-3

  4. From: Ploeg 27-4

  5. What are the goals of TJR? What are the goals of TJR? • Improve quality of life Improve quality of life • Reduce pain • Restore function R t f ti – Movement – Strength • Last throughout life g 27-5 From: Ploeg

  6. From: Ploeg 27-6

  7. Smith & Nephew orthopaedics hip portfolio 27-7 From: Kelman

  8. Clinical performance SPECTRON™ stem SYNERGY™ stem 100% survival rate of the 99.5% Survivorship 99 5% Survivorship SPECTRON stem at 12 4 years 1 97.0% survival rate of 97.0% survival rate of 1. 1 The Charnley Versus the Spectron Hip Prosthesis” The Charnley Versus the Spectron Hip Prosthesis , The Journal of Arthroplasty Vol. 14 No. 14 1999, SPECTRON stem at 9.6 Goran Garellick, et al MD, PhD. years 2 2. “Hip Arthroplasty With a Collared Straight Cobalt- Chrome Femoral Stem Using Second Generation Cementing Technique”, The Journal of Arthroplasty g q , p y 99.7% survival rate of 99 7% i l t f Vol. 15 No. 2 2000, Ashay Kale, MD et al. SPECTRON EF at 7 yrs 3 3. Swedish National Hip Registry, 2000 Report, Henrik Malchau, MD, PhD 4. Bourne, Robert, M.D., F.R.C.S.; Rorabeck, Cecil, M.D., F.R.C.S.; The London Health Sciences Centre M D F R C S Th L d H lth S i C t Experience: Synergy Tapered Hip System; International Hip Meeting. Prague, Czech Republic. May 2001 27-8 From: Kelman ™Trademark of Smith & Nephew. Reg. US Pat. & TM Off.

  9. ANTHOLOGY™ Hip System ANTHOLOGY Hip System • Value proposition Value proposition – The ANTHOLOGY™ system provides the surgeon a press provides the surgeon a press- fit implant that is optimum for all femur types – It is designed to be MIS friendly, reduce dislocations, and be more bone and tissue conserving than previous i th i primary implant designs 27-9 From: Kelman ™Trademark of Smith & Nephew.

  10. From: Materials and Textiles 27-10

  11. Failure Modes Proximal Zone Central Zone • Cement Fracture C t F t • Stem Fracture • Bone-cement interface Distal Zone • Cement Fracture • Bone Fracture • Bone Resorption 27-11 From: Ploeg

  12. From: Materials and Textiles 27-12

  13. From: Ploeg 27-13

  14. How successful are prosthetic j i joints? ? • Relieve pain Relieve pain • Restore function • Most (>90%) last for >10 years M t ( 90%) l t f 10 27-14 From: Ploeg

  15. What artificial biomaterials are most commonly used? l d? • Metals Metals – Stainless steel – Cobalt chrome Cobalt chrome – Titanium alloy • Ceramics – aluminum oxide C i l i id • Polymers – Bone cement (PMMA) – UHMWPE (polyethylene) 27-15 From: Ploeg

  16. From: Ploeg 27-16

  17. From: Ploeg 27-17

  18. Polymers Polymers • Bone cement (PMMA) Bone cement (PMMA) – Exothermic – Toxic effects of monomer Toxic effects of monomer – Shrinkage with polymerization – Grout, not adhesive , • UHMWPE (polyethylene) – Lipid absorption p p – Wear particles – Low coefficient of friction and creep resistant p 27-18 From: Ploeg

  19. From: Ploeg 27-19

  20. What are key design criteria for artificial biomaterials? ifi i l bi i l ? • Restore mechanical function Restore mechanical function • Biocompatibility • Chemically Stable Ch i ll St bl 27-20 From: Ploeg

  21. Requirements for Biomaterials Requirements for Biomaterials • Must re-establish mechanical function with Must re establish mechanical function with healing or replacement: – Structural and mechanical criteria Structural and mechanical criteria – Strength – Stiffness Stiffness – Fatigue life – Wear W – Wear debris 27-21 From: Ploeg

  22. Requirements for Biomaterials Requirements for Biomaterials • Must be biocompatible Must be biocompatible – No inflammatory response – Inflammation causes lymphocyte invasion, Inflammation causes lymphocyte invasion vascular occlusion, tissue necrosis, fibrous tissue formation, prosthesis / implant tissue formation, prosthesis / implant loosening – Not carcinogenic g – Not toxic – Not mutagenic, No immunogenic response Not mutagenic, No immunogenic response 27-22 From: Ploeg

  23. Requirements for Biomaterials Requirements for Biomaterials • Must not be adversely affected by Must not be adversely affected by biological environment, i.e. stable – Non-corrosive (metals) to minimize: Non corrosive (metals) to minimize: – Stress corrosion – Galvanic corrosion Galvanic corrosion – Crevice corrosion – Lipid absorption (polymers) causing property Li id b ti ( l ) i t degradation 27-23 From: Ploeg

  24. Requirements for Biomaterials Requirements for Biomaterials • Manufacturing and Use Manufacturing and Use – Machinability • Ductility (plates must be contoured during use) • Ductility (plates must be contoured during use) – Cost and supply – Requisite size (determined by mechanical Requisite size (determined by mechanical properties) versus available space – Sterilizable Sterilizable – Size of material (i.e. wear debris) biocompatibility doesn’t fix things biocompatibility doesn t fix things 27-24 From: Ploeg

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend